Get the Stockscreener App
204.01
0.97%
-1.99
Pre-market:
203.25
-0.76
-0.37%
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $204.01, with a volume of 4.62M.
It is down -0.97% in the last 24 hours and down -5.81% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$206.00
Open:
$202.28
24h Volume:
4.62M
Relative Volume:
1.23
Market Cap:
$144.26B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
40.39
EPS:
5.051
Net Cash Flow:
$5.26B
1W Performance:
-2.48%
1M Performance:
-5.81%
6M Performance:
+2.29%
1Y Performance:
-0.82%
1-Day Range:
$200.67
$205.00
1-Week Range:
$200.67
$211.04
52-Week Range:
$171.00
$242.80
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
204.01 | 145.67B | 24.57B | 3.60B | 5.26B | 5.051 |
|
TMO
Thermo Fisher Scientific Inc
|
508.10 | 191.08B | 44.56B | 6.73B | 6.29B | 17.74 |
|
IDXX
Idexx Laboratories Inc
|
635.54 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
119.04 | 33.42B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
312.14 | 30.14B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Pall Corporation Appoints Dr. Roland Folz as President - citybiz
Danaher Corporation $DHR Shares Acquired by South Dakota Investment Council - MarketBeat
Kingsview Wealth Management LLC Trims Holdings in Danaher Corporation $DHR - MarketBeat
Danaher to acquire Irvine-based Masimo - Irvine Standard
Danaher (DHR) CFO Matthew Gugino details stock, options and deferred units - Stock Titan
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Biotech Stocks To Follow TodayMarch 2nd - MarketBeat
Fisher Asset Management LLC Increases Position in Danaher Corporation $DHR - MarketBeat
Davis R M Inc. Sells 4,800 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corp. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
TIAA Trust National Association Sells 83,542 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Huntington National Bank - MarketBeat
Erste Asset Management GmbH Sells 65,111 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Stock Holdings Boosted by Intech Investment Management LLC - MarketBeat
Aviso Financial Inc. Sells 15,532 Shares of Danaher Corporation $DHR - MarketBeat
Biotech Stocks To Keep An Eye OnFebruary 28th - MarketBeat
Westfield Capital Management Co. LP Cuts Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Stake Lifted by Harvest Portfolios Group Inc. - MarketBeat
Findlay Park Partners LLP Has $109.94 Million Stake in Danaher Corporation $DHR - MarketBeat
Handelsbanken Fonder AB Sells 9,416 Shares of Danaher Corporation $DHR - MarketBeat
Danaher (NYSE: DHR) to acquire Masimo; MASI proxy materials sent to stockholders - Stock Titan
Promising Biotech Stocks To ConsiderFebruary 27th - MarketBeat
US Bancorp DE Increases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Hohimer Wealth Management LLC Takes Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Where is Danaher Corporation (DHR) Headed? - Insider Monkey
Danaher Corporation Archives - Strata-gee.com
Masimo Acquired by Danaher: Is This the Conclusion to an Epic Saga? - Strata-gee.com
Danaher said to near $10 billion deal for Masimo, FT reports - MSN
Masimo earnings in focus as Danaher deal looms - Investing.com
Danaher Corporation $DHR Shares Sold by Montrusco Bolton Investments Inc. - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Buys 56,407 Shares of Danaher Corporation $DHR - MarketBeat
Primecap Management Co. CA Increases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Mar Vista Investment Partners LLC Sells 28,411 Shares of Danaher Corporation $DHR - MarketBeat
TD Asset Management Inc Has $109.57 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence - GlobeNewswire Inc.
Cytiva expands Fast Trak process development and validation services facility in India - Pharmabiz.com
Danaher (DHR) SVP reports 101-share tax-withholding disposition at $209.19 - Stock Titan
Danaher (DHR) SVP reports Form 4 tax-withholding of 344 shares - Stock Titan
Danaher (NYSE: DHR) VP logs tax-related share disposition - Stock Titan
Danaher (NYSE: DHR) EVP uses 189 shares to cover tax withholding - Stock Titan
[Form 4] DANAHER CORP /DE/ Insider Trading Activity - Stock Titan
Masimo's board backs Danaher's $9.9B cash acquisition proposal - MSN
Danaher Corporation (NYSE:DHR) to Issue Dividend Increase$0.40 Per Share - MarketBeat
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
Waratah Capital Advisors Ltd. Grows Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Acquired by RWA Wealth Partners LLC - MarketBeat
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks? - Barchart.com
Decoding Danaher Corp (DHR): A Strategic SWOT Insight - GuruFocus
Danaher declares $0.40 quarterly dividend per share - Investing.com
Danaher Corp announces quarterly dividend of $0.40 per share - marketscreener.com
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):